Sonoma Biotherapeutics Receives $45M Milestone Payment from Regeneron for Treg Therapy Collaboration
Key Highlights Sonoma Biotherapeutics receives $45 million milestone payment from Regeneron. Collaboration focuses on engineered Treg therapies for autoimmune diseases. Sonoma Bio…